Production capacity of Remdesivir ramped up by more than 3-times

India now has capacity to manufacture 12.25 mn vials a month

Production capacity of key antiviral injectable drug Remdesivir used to treat Covid-19 has been ramped up by more than three-times in the last few months to 12.249 million vials per month by June. The Centre is also trying to build an inventory or a buffer stock of this injectable before a third wave hits.

The drug was in short supply in April and May when the country was witnessing a massive second wave of infections, and manufacturers were in the middle of ramping up capacities.

In a response given in the Rajya Sabha, Health Minister Mansukh Mandaviya said that the Drugs Controller